↓ Skip to main content

Cochrane Database of Systematic Reviews

Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients

Overview of attention for article published in Cochrane database of systematic reviews, October 2005
Altmetric Badge

Citations

dimensions_citation
237 Dimensions

Readers on

mendeley
149 Mendeley
Title
Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients
Published in
Cochrane database of systematic reviews, October 2005
DOI 10.1002/14651858.cd003961.pub2
Pubmed ID
Authors

Angela C Webster, Rod RS Taylor, Jeremy R Chapman, Jonathan C Craig

Abstract

Kidney transplantation is the treatment of choice for most patients with end-stage renal disease (ESRD). Standard protocols in use typically involve three drug groups each directed to a site in the T-cell activation or proliferation cascade which are central to the rejection process: calcineurin inhibitors (e.g. cyclosporin, tacrolimus), anti-proliferative agents (e.g. azathioprine, mycophenolate mofetil) and steroids (prednisolone). It remains unclear whether new regimens are more specific or simply more potent immunosuppressants.

Mendeley readers

The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Unknown 147 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 15%
Researcher 19 13%
Student > Bachelor 18 12%
Student > Ph. D. Student 17 11%
Other 11 7%
Other 24 16%
Unknown 37 25%
Readers by discipline Count As %
Medicine and Dentistry 61 41%
Nursing and Health Professions 13 9%
Pharmacology, Toxicology and Pharmaceutical Science 9 6%
Agricultural and Biological Sciences 4 3%
Computer Science 3 2%
Other 16 11%
Unknown 43 29%